Methodology

All entries for: GRT Therapeutics Inc.

June 11, 2026

GRT Therapeutics Inc.

Orphan Drug Designation

treatment of Duchenne muscular dystrophy

Disease Area: Rare Diseases
Source
Scroll to Top